Prince­ton con­sid­ers menin­gi­tis vac­cine un­ap­proved in U.S.

The Washington Times Daily - - Nation -

PRINCE­TON | Prince­ton Univer­sity of­fi­cials are de­cid­ing whether to give stu­dents a menin­gi­tis vac­cine that hasn’t been ap­proved in the U.S. to stop the spread of the disease.

The Food and Drug Ad­min­is­tra­tion last week ap­proved im­port­ing Bexsero for pos­si­ble use on Prince­ton’s cam­pus. The vac­cine is ap­proved in Europe and Aus­tralia. It’s the only vac­cine for use against the type B meningo­coc­cal bac­te­ria.

Health of­fi­cials con­firmed the Ivy League school’s sev­enth case of menin­gi­tis last week. Six stu­dents and a vis­i­tor have been di­ag­nosed since March.

Menin­gi­tis can be spread through kiss­ing, cough­ing or lengthy con­tact.

The school told stu­dents to wash their hands, cover their mouths when cough­ing and not share items such as drink­ing glasses and eat­ing uten­sils. de­fen­dant James Holmes to un­dergo fur­ther eval­u­a­tion of his san­ity, ac­cord­ing to court records made pub­lic Mon­day — a de­vel­op­ment that sug­gests the first ex­am­i­na­tion might have found he was in­sane.

The find­ings of the first eval­u­a­tion have not been pub­licly dis­closed, but long­time Den­ver de­fense at­tor­ney Dan Recht said it was highly un­likely pros­e­cu­tors would ask for fur­ther

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.